Jiangsu Nanfang Medical Co (603880) Fair Value & Analysis
Healthcare · CN · Market cap 2.2B CNY
Fair value as of: Jun 24, 2026
Analysis
Jiangsu Nanfang Medical Co (603880) currently trades at ¥7.49, while our model-based Fair Value estimate is ¥1.89 — implying the stock looks roughly 74.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide adhesive, masks, and nitrile gloves, as well as customized products. The company was founded in 1990 and is headquartered in Changzhou, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Jiangsu Nanfang Medical Co (603880) undervalued?
What is the fair value of 603880?
What is the quality score of 603880?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.